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Postoperative pain after laparoscopic cholecystectomy can be severe. Despite multimodal analgesia regimes, administration of high
doses of opioids is often necessary. This can further lead to several adverse effects such as drowsiness and respiratory impairment
as well as postoperative nausea and vomiting.This will hinder early mobilization and discharge of the patient from the day surgery
setting and is suboptimal in an Early Recovery after Surgery setting. The ultrasound-guided Erector Spinae Plane (ESP) block is a
novel truncal interfascial block technique providing analgesia of the thoracic or abdominal segmental innervation depending on the
level of administration. Local anesthetic penetrates anteriorly presumably through the costotransverse foramina to the paravertebral
space.We demonstrate the analgesic efficacy of the ESP block in a case series of three patients scheduled for ambulatory laparoscopic
cholecystectomy.
1. Introduction
Laparoscopic cholecystectomy is associated withmoderate to
severe pain despite all currently available multimodal anal-
gesic regimes [1–3]. The ultrasound-guided Erector Spinae
Plane (ESP) block is a novel truncal interfascial regional
technique [4]. Two variations of the ESP block for thoracic
and abdominal procedures have recently been described
in literature. The injection site is either at the level of T5
transverse process, resulting in spread between the C7 and
T8 segmental levels [4–6], or at the levels of the T7-T9
transverse processes, resulting in spread between the T6
and T12 segmental levels [7–9]. Local anesthetic penetrates
anteriorly presumably through the costotransverse foramina
to the paravertebral space and it can thus be described as an
indirect paravertebral block [8]. Several approaches targeting
the same interfascial plane have been described in the current
literature with variable injection sites [10, 11]. However, the
ESP block is presumably the most promising due to its
anatomically close proximity to the costotransverse foramina.
2. Case Presentation
Written informed consent for publication was obtained from
all three patients.There was no need for approval by the Cen-
tral Denmark Region Committees on Biomedical Research
Ethics.
2.1. Patient 1. A 42-year-old man with a body mass index
(BMI) of 35.8 kg/m2 presented for elective ambulatory lap-
aroscopic cholecystectomy. He was diagnosed with obstruc-
tive sleep apnea treated with nightly continuous positive
airway pressure (CPAP) therapy. He was otherwise healthy
and did not take any medication. A bilateral ESP block was
performed just prior to surgery. The patient was sitting up
and the level of theT7 transverse processwas located just 3 cm
laterally from themidline using a 15–6MHz linear ultrasound
probe (SonoSite, X-Porte, Bothell, Washington) oriented
sagittally (Figure 1).The cross-sectional view of the transverse
process was centered on the ultrasound screen and the over-
lying trapezius, and erector spinae muscles were identified.
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Figure 1: Ultrasound image showing subcutis, trapezius muscle, erector spinae muscle, transverse process of T7 (TP), needle path (in red),
and spread of local anesthetic (LA).
Under aseptic conditions, a 22-gauge 80mm block needle
(Pajunk, Geisingen, Germany) was inserted in-plane at a
shallow angle of approximately 30–40∘ in a cranial-to-caudal
direction aiming at the needle tip at the posterior aspect
of the transverse process. Bony contact was established,
and hydrodissection with 2mL of isotone saline confirmed
correct needle tip position on the transverse process and deep
to the epimysium of the erector spinae muscle. The needle
tip was then redirected and advanced slightly caudad to the
transverse process. After hydrodissection with yet another
2mL of isotonic saline, injection of 20mL ropivacaine 0.5%
was performed ensuring both cranial and caudal spread of
local anesthetic in the fascial plane deep to the erector spinae
muscle, lifting the muscle off the transverse processes. The
procedure was repeated in a similar fashion on the contralat-
eral side. Preoperative multimodal analgesia was achieved
with paracetamol 1 g and ibuprofen 400mg orally. General
anesthesia was induced with propofol 180mg and remifen-
tanil 350 𝜇g and maintained with propofol 65𝜇g/kg/min
and remifentanil 0.33 𝜇g/kg/min. Intubation was uneventful.
The patient received intraoperative dexamethasone 8mg IV,
droperidol 0.625mg IV, and ondansetron 4mg IV. Fentanyl
50 𝜇g IV was also administered intraoperatively 30 min
prior to emergence from anesthesia. Pneumoperitoneumwas
achieved with insufflation of carbon dioxide (CO
2
) with
a pressure of 12mmHg. At the end of the uncomplicated
surgical procedure the laparoscopic port sites were infiltrated
with 20mL of ropivacaine 0.2%, and CO
2
was evacuated.
Extubation was uneventful but in the postanesthesia care
unit (PACU), the patient was drowsy and complained about
dyspnea, which was suspected to be caused by a combination
of mild intermittent airway obstruction, anxiety, and pain.
It was thus treated with a nasal airway, fentanyl 50 𝜇g IV,
and morphine 10mg orally. Once fully awake, the patient
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Table 1: Data from all three patients on opioid consumption, pain scores, and other variables.
Patient 1 Patient 2 Patient 3
Discomfort with block placement (0–10) 1 0 4
In-hospital opioids∗
Intraoperative (during surgery) 15mg 15mg 15mg
Postoperative (in PACU) 25mg 10mg 15mg
NRS in PACU (0–10)
First NRS 2 2 3
Highest NRS 3 2 3
PONV in PACU No No No
Time to discharge from PACU 2 h 56min 3 h 32min 2 h 1min
Opioid requirements after discharge∗
1st postoperative day 10mg 20mg 20mg
2nd postoperative day 0mg 10mg 0mg
In total 1st week 10mg 40mg 20mg
Mean NRS after discharge (0–10)
1st postoperative day 4 3 4
2nd postoperative day 3 2 2
7th postoperative day 0 0 0
PDNV
1st postoperative day No No No
2nd postoperative day No No No
Unscheduled healthcare contacts No No No
(within 1st week after surgery)
Resumption of ADL (days) 5 7 10
NRS: numerical rating scale. PACU: postanesthesia care unit. PDNV: postdischarge nausea and vomiting. ADL: activities of daily living. ∗Oral morphine
equivalents. PONV: postoperative nausea and vomiting.
denied that the incident was due to pain but reported that
he had been anxious because of dyspnea. Numerical rating
scale (NRS) was 2/10 and remained below 3/10 for the rest
of his stay in the PACU and he did not receive any further
medication. He was discharged to home 2 hours and 56 min
after arriving in the PACU.
2.2. Patient 2. A 49-year-old woman (BMI 28.4 kg/m2) was
scheduled for ambulatory laparoscopic cholecystectomy. She
did not present any comorbidities besides being a smoker
(40 pack years). The ESP block was performed 45min
preoperatively at the level of the T7 transverse process as
described above under mild sedation with fentanyl 50𝜇g
IV. She received standard premedication with paracetamol
and ibuprofen. Induction was performed with propofol
190mg and remifentanil 250𝜇g and maintained with propo-
fol 70 𝜇g/kg/min and remifentanil 0.3 𝜇g/kg/min. Intubation
and extubation were uneventful. Intraoperative medication
was similar to patient 1. The first NRS in the PACU was
2/10 and subsequent scores were 0–2/10. Morphine 10mg
was administered orally due to earlier standard protocols,
although the patient did not have any pain complaints. The
patient was discharged to home from the PACU 3 hours and
32min after arrival.
2.3. Patient 3. A 65-year-old woman (BMI 33.3 kg/m2) also
presented for ambulatory laparoscopic cholecystectomy. Her
only comorbidities were depression and anxiety, which were
well controlled with oral nortriptyline and pregabalin. Pre-
medication with paracetamol and ibuprofen was similar to
the other two cases described above. The ESP block was
carried out 45 min preoperatively at the level of the T7
transverse process similar to patients 1 and 2. Induction
was achieved with propofol 140mg and remifentanil 250𝜇g
andmaintained with propofol 71𝜇g/kg/min and remifentanil
0.13 𝜇g/kg/min. She also received intraoperative dexametha-
sone, droperidol, ondansetron, and port site infiltration. Fen-
tanyl 100 𝜇g was administered intraoperatively. After uncom-
plicated surgery and extubation the patient was transferred
to the PACU. In the PACU the patient only complained of
minor pain (NRS < 3/10). She received fentanyl 50 𝜇g, and at
discharge to home 2 hours and 1min later her NRS score was
0/10.
Data on all three cases are summarized in Table 1.
3. Discussion
In developed countries, approximately 15% of asymptomatic
adults from the general population have gallstones, and
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nearly 10% of these individuals develop symptoms or compli-
cations requiring treatment within five years [12]. Cholecys-
tectomy is the golden standard in treating symptomatic gall-
bladder disease, such as acute cholecystitis [12]. In Denmark,
about 9000 cholecystectomies are performed annually, and
93% of these are performed as laparoscopic procedures [13].
Currently, about 40% of the laparoscopic cholecystectomies
are performed as ambulatory surgery [13], and approximately
15% of the ambulatory patients cannot be discharged on the
day of the surgery most often due to pain or postoperative
nausea and vomiting (PONV) [12].
Pain can be severe after laparoscopic cholecystectomy [2,
3]. This pain has three components: incisional pain (somatic
pain from the trocar site), visceral pain, and shoulder pain
(presumably referred visceral pain) [2, 3]. Pain in general is
most intense on the day of the surgery (peaking within the
first 4–8 hours after surgery) and subsequently diminishes
to low levels within 2–4 days [2, 3, 14]. The intensity of
visceral pain dominates over incisional pain (especially peri-
umbilical), which dominates over shoulder pain [2]. Three
possible mechanisms for visceral pain have been proposed:
(1) irritative effect on the diaphragmatic peritoneum of the
insufflated CO
2
gas because of conversion to carbonic acid,
(2) diaphragmatic muscle fiber stretching with tearing of
muscular blood vessels and traction on nerve fibers, and
(3) retained residual pockets of gas in the abdominal cavity
[2, 3, 15]. About 30–50% of patients suffer from shoulder pain
during the first postoperative day, most often on the right
side [15]. It is usually of short duration and low intensity
[2, 15]. The mechanism of shoulder pain is multifactorial and
poorly understood, but it is thought to be subdiaphragmatic
irritation transmitted via the phrenic nerve causing referred
pain in the C4 dermatome [2, 15].
For comparison, regarding how the normal patient with-
out a block does at our institution, we have carried out a
survey from the first 50 laparoscopic cholecystectomies at our
department in 2016 (yet unpublished data) with multimodal
analgesia (paracetamol, ibuprofen, dexamethasone, port site
infiltration, and opioids as rescue medication). Immediately
after awakening, about half of patients (56%) had minor pain
(NRS 0–3) and about half of patients (44%) had moderate
to severe pain (NRS 4–10). About one-fourth of the patients
(24%) just hadminor pain (NRS 0–3) during the entire PACU
stay, whereas about three-fourths of the patients (76%) at
some point had moderate to severe pain (NRS 4–10). Inter-
estingly, only half of the patients who initially just had minor
pain (NRS 0–3) continued having minor pain, whereas the
other half of the patients with initial minor pain experienced
stronger pain later during the PACU stay. Another point of
interest is that 1 out of 7 patients (14%) at some point in the
PACU had excruciating pain (NRS 8–10), which corresponds
to earlier reported numbers [16]. The patients received on
average 47mg morphine (oral equivalents) intraoperatively
(standard deviation 14.8) and 45mg postoperatively (SD 31.8)
during the PACU stay. Prevalence of PONV in the PACU
was 40%, requiring additional pharmacological treatment
besides the administered standard triple prophylaxis. The
average discharge time was 3.5 hours (SD 1.4), and 20%
were admitted overnight most often due to pain. The clinical
course of patients discharged after ambulatory laparoscopic
cholecystectomy (without block) in our department has been
previously described [14]. Median pain intensity was NRS 7
on the day of surgery and NRS 6, 5, 4, 1 on the 1st, 2nd, 3rd,
7th postoperative day, respectively [14]. After discharge 27.9%
of the patients had unscheduled pain-related contacts with
healthcare services, most often in the 1st postoperative week
[14].
Opioid requirements at home after ambulatory laparo-
scopic cholecystectomy are variable [17]. According to Hill
et al. about 35% of discharged patients did not take opioids,
about 25% took 1–10 pills of oxycodone 5mg (equivalent to
7.5mg oral morphine), about 25% took 11–15 pills, and about
15% took more than 15 pills [17].
PONV has previously been described to exist in about
10% of patients after laparoscopic cholecystectomy with
multimodal anesthesia [2, 16]. Pain is strongly associatedwith
PONV [16]. Pain may directly worsen PONV, and PONV in
itself may aggravate the pain [16].
The concept of “fast-track surgery” or Enhanced Recov-
ery after Surgery (ERAS) programs applied on laparoscopic
cholecystectomy requires multimodal analgesia including
paracetamol, NSAIDs and dexamethasone in addition to opi-
oids as rescue medication [1–3, 18]. Port site local infiltration
has been shown to provide some pain relief, as opposed to
intraperitoneal local anesthetic [3, 19]. Low pressure pneu-
moperitoneum (<10mmHg) has been shown to decrease pain
scores and analgesic consumption as opposed to standard
pressure (12–16mmHg) [3, 15, 20]. Active gas aspiration and
pulmonary recruitment maneuvers after the completion of
the surgical procedure empty the abdominal cavity from
residual CO
2
gas and reduce postoperative overall pain [15,
21]. This is especially true for shoulder pain and possibly also
for (upper) abdominal pain [21]. Classical lateral Transversus
Abdominis Plane (TAP) blocks have shown marginal benefit
in reducing opioid consumption and pain scores in the first
6–8 hours similar to that of local port site infiltration [19, 22].
TAP blocks only provide somatic analgesia [19].
Since its first description in 2016 numerous case reports
about the ESP block have been described for thoracic and
abdominal procedures including thoracic neuropathic pain
[4, 6], ventral hernia repair [7], bariatric surgery [8], thora-
cotomywith lobectomy [5], rib tumor surgery [23], andmajor
lower abdominal surgery [9].
Unlike earlier beliefs, the fascial planes in the paraver-
tebral region may not be bound true compartments [24].
Local anesthetic seems to spread along the dorsal rami of
the thoracic spinal nerves, which run through the costotrans-
verse foramina of Cruveilhier. Ligaments like the superior
costotransverse ligament seem to have fenestrations [24],
and these porous anatomical structures can be speculated
to allow anterior spread of the local anesthetic. The needle
tip positioning for the ESP block is technically simple, safe,
and away from the paravertebral space and the pleura. The
ESP block injectate reaches the dorsal and ventral rami of
the thoracic spinal nerves as well as the sympathetic gray
communicating rami [4, 7, 23]. The ESP block generates
extensive blockade of the posterior, lateral, and anterior
thoracic and abdominal wall and thus alleviates incisional
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pain. In addition, the ESP blocks visceral autonomic pain
[6, 8].
There are several unanswered questions to address.
Firstly, the ESP block has so far only been described in case
reports, and the promising results must be validated in future
randomized clinical trials. Secondly, the optimal time for
block placement should be considered. In general, this is
the best achieved preoperatively in the awake patient. About
three-fourths of the patients experience moderate to severe
pain some time during the postoperative period. A minority
of the patients experience excruciating pain.Thirdly, optimal
volume and concentration of local anesthetic are unknown.
Previous authors have mainly used ropivacaine 0.5% 20mL
providing analgesia for about 20 hours reducing opioid
consumption to about one-third [7]. A similar reduction
from the expected opioid usage was seen in our three cases
(see Table 1). The opioid sparing potential may be especially
advantageous in the ambulatory setting, where pain and/
or PONV may delay or even prevent same-day discharge.
Fourthly, additives like glucocorticosteroids (off-label use)
can be considered [7], which presumably would extend block
duration beyond 24 hours.
4. Conclusion
The three reported cases illustrate the efficacy of the ESP
block for somatic and visceral pain relief after upper abdom-
inal laparoscopic cholecystectomy. The results must be vali-
dated in future randomized controlled trials.
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